HIV Medications for HIV Prevention

DO. SEE. HEAR. KNOW. Visit TheBody.com's 2008 World AIDS Day Center >>

BROWSE TOPICS IN HIV TREATMENT:

HIV Treatment: Home Page

Just Diagnosed

HIV Medications

First Steps to Treatment

HIV Drug Resistance

Switching or Stopping Treatment

Third Line/Rescue Treatment

Hepatitis C Coinfection

Women & Pregnancy

HIV Treatment for Children

Side Effects & Health Problems

Research & Experimental Drugs

HIV Treatment in the Developing World

Basics | News & Research

Basics

Before and After: PrEP and PEP (Summer 2007)
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America
Q & A: CDC's Clinical Studies of Pre-Exposure Prophylaxis for HIV Prevention (April 2007)
To read PDF, click here
From U.S. Centers for Disease Control and Prevention
CDC Trials of Daily Oral Tenofovir for Preventing HIV Infection (December 7, 2005)
To read PDF, click here
From U.S. Centers for Disease Control and Prevention
What's "The T"? (July/August 2005)
An AIDS advocate in Georgia explains why it's important to study tenofovir's potential as an HIV prevention pill.
To read PDF, click here
In Survival News, from AIDS Survival Project
CDC's Clinical Studies of Daily Oral Tenofovir for HIV Prevention (June 2005)
To read PDF, click here
From U.S. Centers for Disease Control and Prevention

News & Research

For Post-Exposure HIV Prevention, Viread May Be Gentler Option than Retrovir (April 17, 2008)
From Reuters Health
New Frontiers in HIV Prevention: Male Circumcision and Pre-Exposure Prophylaxis in the United States -- An Interview at CROI 2007 With Patrick Sullivan, Ph.D., and Lynn Paxton, M.D., M.P.H. (February 27, 2007)
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
HIV Clinical Trial Aiming to Increase Participation of Black MSM (January 11, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Antiretroviral Drugs as Prevention Tools: PEP, PrEP and Prevention for Positives (September 27, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
PrEP Studies Show Possible Effectiveness; Scientists Say Further Tests Must Be Completed for Confirmation (August 14, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Can a Pill a Day Keep HIV Away? Educators Warn Against Jumping the Gun (May 5, 2006)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Some MSM Already Using Tenofovir as Method of HIV Prevention, Outside of Clinical Trials (December 19, 2005)
Physicians and HIV prevention experts say tenofovir has been sold in gay dance clubs around the country and prescribed by some physicians for prevention.
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
We Must Not Let Protestors Derail Trials of Pre-Exposure Prophylaxis for HIV (September 2005)
Joep Lange, former president of the International AIDS Society, says the protests reveal a major flaw in global AIDS activism.
In PLoS Medicine
Family Health International Ends Viread Clinical Trial in Cameroon (August 12, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Family Health International Will Seek Support From Gates Foundation for Tenofovir Trials to Prevent HIV (August 5, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Antiretroviral Drug Researchers, AIDS Advocates Fail to Reach Consensus Over Viread Trials in Developing Countries (May 24, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Fact Sheet on "Project T": A Safety Study of Daily Oral Tenofovir to Prevent HIV Infection in HIV-Negative Men Who Have Sex With Men (PDF) (December 2004)
Study sites are in San Francisco and Atlanta.
From San Francisco Department of Public Health
Alternative HIV Prevention Methods: The World's Most Important AIDS Research? (November 2004)
Microbicides and pre-exposure HIV treatment may be easier to develop than vaccines and less controversial than behavioral changes.
To read PDF, click here
In Project Inform Perspective, from Project Inform
Regrettably, Cambodia Stops Important Tenofovir Prevention Trial (August 23, 2004)
The study's cancellation is a major setback for global HIV prevention efforts, writes AIDS advocate John James.
In AIDS Treatment News, from AIDS Treatment News
Cambodian Sex Workers Refuse to Participate in Tenofovir HIV Prevention Trial (March 30, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
"It's OK, I'm on the AIDS Pill" (February 26, 2004)
Tenofovir (Viread) is being tested as a "morning-after" pill to prevent HIV infection. But if it's found to work, could it cause more problems than it solves?.
In Wired News
Tenofovir as Pre-Exposure Prophylaxis (February 2003)
From American Foundation for AIDS Research
Prevention: New Approach Will Test Tenofovir for Persons at High Risk (November 22, 2002)
A brief analysis of the study's significance for women.
In AIDS Treatment News, from AIDS Treatment News
$6.5M Set Aside to Study Tenofovir as HIV-Prevention Pill (November 5, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.